Physician profile
William J Baker
NPI 1124196787
$2,130.19
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $781 · 2021: $389.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $481.70 | 2019-2021 | |
| Lilly USA, LLC | $308.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $247.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.22 | 2019-2021 | |
| Glaxosmithkline, LLC. | $104.38 | 2019-2020 | |
| Amarin Pharma, INC. | $91.91 | 2019-2021 | |
| Pfizer INC. | $87.11 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $86.52 | 2019 | |
| Esperion Therapeutics, INC. | $78.98 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $75.42 | 2019-2020 | |
| Daiichi Sankyo INC. | $48.12 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.24 | 2019 | |
| Abbvie INC. | $44.17 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.07 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $34.97 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $30.78 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $28.58 | 2019 | |
| Amgen INC. | $28.14 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $15.89 | 2020 | |
| Astellas Pharma US INC | $15.77 | 2019 | |
| Antares Pharma, INC. | $15.68 | 2019 | |
| Eisai INC. | $13.57 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.52 | 2021 | |
| Allergan, INC. | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.